ALGN vs. GH: A Head-to-Head Stock Comparison
UpdatedHere’s a clear look at ALGN and GH, comparing key factors like performance, valuation metrics, dividends, and financial strength. It’s built for investors or anyone curious to see how these two stocks match up.
Company Overview
ALGN dominates in value with a market cap of 12.46 billion USD, eclipsing GH’s 4.60 billion USD by roughly 2.71×.
With betas of 1.68 for ALGN and 1.49 for GH, both show similar volatility profiles relative to the overall market.
| Symbol | ALGN | GH |
|---|---|---|
| Company Name | Align Technology, Inc. | Guardant Health, Inc. |
| Country | US | US |
| Sector | Healthcare | Healthcare |
| Industry | Medical - Devices | Medical - Diagnostics & Research |
| CEO | Mr. Joseph M. Hogan | Dr. Helmy Eltoukhy Ph.D. |
| Price | 171.91 USD | 37.09 USD |
| Market Cap | 12.46 billion USD | 4.60 billion USD |
| Beta | 1.68 | 1.49 |
| Exchange | NASDAQ | NASDAQ |
| IPO Date | January 30, 2001 | October 4, 2018 |
| ADR | No | No |
Performance Comparison
This chart compares the performance of ALGN and GH over the past year by tracking the growth of an initial $10,000 investment in each (starting one year ago).
Hover over the lines to see the investment’s value and total return (%) at specific dates.
Data is adjusted for dividends and splits.
Valuation Metrics Comparison
The section examines key financial ratios to assess the valuation of ALGN and GH based on earnings, cash flow, sales, and book value. Pay attention to the following notable points where extreme values stand out.
- GH shows a negative P/E of -11.03, highlighting a year of losses, whereas ALGN at 30.88 trades on solid profitability.
- GH carries a sub-zero price-to-book ratio of -18.32, indicating negative equity. In contrast, ALGN (P/B 3.33) has positive book value.
- GH reports a negative Price-to-Free Cash Flow ratio of -15.07, showing a cash flow shortfall that could threaten its operational sustainability, while ALGN at 19.76 maintains positive cash flow.
| Symbol | ALGN | GH |
|---|---|---|
| Price-to-Earnings Ratio (P/E, TTM) | 30.88 | -11.03 |
| Forward PEG Ratio (TTM) | 2.92 | 0.46 |
| Price-to-Sales Ratio (P/S, TTM) | 3.13 | 5.94 |
| Price-to-Book Ratio (P/B, TTM) | 3.33 | -18.32 |
| Price-to-Free Cash Flow Ratio (P/FCF, TTM) | 19.76 | -15.07 |
| EV-to-EBITDA (TTM) | 14.56 | -13.08 |
| EV-to-Sales (TTM) | 2.94 | 6.72 |
| EV-to-Free Cash Flow (TTM) | 18.56 | -17.07 |
Dividend Comparison
Neither ALGN nor GH currently pays a dividend yield; this often indicates they are reinvesting earnings for growth, prioritizing long-term expansion over immediate cash returns to shareholders.
| Symbol | ALGN | GH |
|---|---|---|
| Dividend Yield (TTM) | 0.00% | 0.00% |
Financial Strength Metrics Comparison
This section dives into the financial resilience of ALGN and GH, spotlighting key metrics like liquidity, leverage, and debt coverage. Check out the standout observations below where notable differences or extremes pop up.
- GH has negative equity (debt-to-equity ratio -5.21), suggesting asset shortfalls, whereas ALGN at 0.03 preserves healthier equity coverage.
- GH carries a debt-to-assets ratio of 0.97, suggesting substantial asset funding via debt, while ALGN at 0.02 opts for a more conservative financing structure.
- ALGN shows “--” (minimal interest expense), but GH is in the red with interest coverage -166.83, signaling a net operating loss.
| Symbol | ALGN | GH |
|---|---|---|
| Current Ratio (TTM) | 1.21 | 4.11 |
| Quick Ratio (TTM) | 1.08 | 3.76 |
| Debt-to-Equity Ratio (TTM) | 0.03 | -5.21 |
| Debt-to-Assets Ratio (TTM) | 0.02 | 0.97 |
| Interest Coverage Ratio (TTM) | -- | -166.83 |